Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
March 2024
View This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2024
View This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
TS SciComm
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Webinars
ADVERTISEMENT
404
Not Found
Is this what you were looking for?
tag biotech biobusiness business cell molecular biology clinical trials
Betting on Biotech
Scott Veggeberg
| Apr 5, 1993
| 10 min read
Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.
Can “Gene Writing” Deliver What Gene Editing Can’t?
Dan Robitzski
| Dec 12, 2022
| 10+ min read
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?
2022 Top 10 Innovations
The Scientist
| Dec 12, 2022
| 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
The Pet Health Industry Takes on Canine Cancer
Diana Kwon
| Oct 17, 2022
| 9 min read
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
Keeping Up with IP
Kate Yandell
| Sep 1, 2014
| 8 min read
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
The Growth of Iowa Biotech
Jenny Rood
| Aug 1, 2016
| 7 min read
The state’s industry draws inspiration from medicine as well as agriculture.
Banking on iPSCs
Kerry Grens
| Sep 1, 2014
| 5 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Banking on iPSCs
Kerry Grens
| Jun 29, 2014
| 6 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Natural Killer Cell Therapies Catch Up to CAR T
Bianca Nogrady
| Apr 1, 2020
| 8 min read
There’s a new cell-based cancer immunotherapy on the block.
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Claire Asher
| Apr 1, 2019
| 9 min read
Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.
Run a Search
ADVERTISEMENT